Skip to content

Category: News

More Umbrella Trials Needed to Advance Precision Medicine in Lung Cancer, Expert Suggests

Further Optimizing the Treatment of Non-Driver NSCLC

Future Focus on Combinations, Biomarkers in Metastatic NSCLC

Master Protocols Are Both Welcome And Inevitable – US FDA's Woodcock

Master Protocols in Practice

Bayesian Adaptive Randomization: A Q&A With Brian M. Alexander MD, PhD

Cure Today – Basket Cases: Changing the Way Cancer Is Treated

Inside Health Policy – Woodcock Says Drug Development Paradigm Needs To Change, But Not At FDA

OncLive – New Trial Designs Hope to Enhance Biomarker Discovery

UAB News – Two major national clinical trials available for lung cancer patients at UAB